Duke Cancer Institute
Patient Care
Research Programs
Explore all health services at muto-logo.gif

Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient Care Services
  • Support Services
  • Physicians
  • Locations
  • Clinical Trials
  • Patient and Visitor Guide
  • Health Library
  • About Us

Quick Links

  • Appointments
  • Referring Physicians
  • Giving to DCI
Home > Patient Care Services > Leukemias, Lymphomas, and Myelomas > Programs > Hematologic Malignancies Program
Jumbo Large Regular Text:
Print
Leukemias, Lymphomas, and Myelomas
About
Care Guides Support Services Clinical Trials News Events Patient Stories Appointments
Programs
Hematologic Malignancies Program Duke Center for Chronic Lymphocytic Leukemia
Physicians
Locations

Hematologic Malignancies Program

Make an appointment

888-ASK-DUKE
(888-275-3853)

Cancer Center Calendar

In This Section

Care Guides

  • Treatment Options for Leukemias and Lymphomas
  • Treatment Options for Multiple Myeloma

Clinical Trials

  • Learn about cancer clinical trials testing the latest treatment ideas

Related Content

Health Library

  • Research Highlights: Stem Cell Research

Services

  • Adult Bone Marrow Transplants

On Other Web Sites

Duke Resources

  • Hematologic Malignancy Program
  • Duke Division of Cellular Therapy

Share

The Duke Hematologic Malignancies Program is a leading national center for hematologic cancers, combining compassionate medical care with state-of-the-art science to improve outcomes for nearly 1,000 patients with a cancer of the blood who come to the Duke Cancer Institute each year.

Duke’s Hematologic Malignancies Program treats patients battling leukemias, lymphomas, myelomas, and other types of cancer of the blood:

  • Acute leukemias
    • Acute lymphoblastic leukemia (ALL)
    • Acute myelogeneous leukemia (AML)
    • Acute non-lymphocytic leukemia (ANL)
    • Acute promyelocytic leukemia (APML)
    • Acute biphenotypic leukemia
    • Acute undifferentiated leukemia
    • Erythroid leukemia
    • Megakaryocytic leukemia
  • Chronic leukemias
    • Chronic myelogenous leukemia (CML)
    • Chronic lymphocytic leukemia (CLL)
  • Myelodysplasias or myeloproliferative diseases
    • Refractory anemia
    • Refractory anemia with ringed siderblasts
    • Refractory anemia with excess blasts
    • Chronic myelomonocytic leukemia (CMML or CMMoL)
    • Agnogenic myeloid metaplasia
    • Myelofibrosis
    • Essential thrombocytosis
    • Polycythemia vera
  • Lymphoproliferative disorders
    • Non-Hodgkin’s lymphoma (NHL)
    • Hodgkin’s lymphoma (HD)
    • Mantle cell lymphoma
    • Follicular lymphoma
    • Diffuse large cell lymphoma
    • Post transplant lymphoproliferative disorder
    • Viral induced symphomas
    • Multiple myeloma
    • Plasma cell leukemia
    • Waldenstrom’s macroglobulinemia
  • Other marrow disorders
    • Aplastic anemia
    • Paroxysmal nocturnal hemoglobinuria (PNH)
    • Pure red cell aplasia

Our program takes a holistic approach to address the medical, emotional, and practical needs of our patients. We alleviate stress and pain through healing touch, massage, aromatherapy, counseling, and patient support programs.

We take particular care to address the needs of our elderly patients, whose physiologic processes require a gentler approach to treatment.

For patients who have recurrent cancers, we provide a seamless transition to Duke's internationally renowned adult bone marrow and stem cell transplant team.

Appointments

Learn how to make an appointment at the Duke Cancer Institute.

Facebook
Twitter
YouTube
Contact Us | Careers | Make a Gift | Site Map
Duke Medicine | Duke School of Medicine | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Aug. 22, 2011
Published: Sept. 11, 2006
URL: http://www.dukehealth.org/cancer/patient-care-services/leukemias-and-lymphomas/programs/hematologic_malignancies